Skip to main content
Journal cover image

Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

Publication ,  Journal Article
Levin, ED; Slade, S; Johnson, M; Petro, A; Horton, K; Williams, P; Rezvani, AH; Rose, JE
Published in: Eur J Pharmacol
December 14, 2008

Nicotine intake constitutes a principal mechanism for tobacco addiction. In addition to primary effects on nicotinic acetylcholine receptors, nicotine has cascading effects, which may also underlie its neurobehavioral actions. Nicotine induces serotonin (5-HT) release, which has not classically been thought to be involved in tobacco addiction as dopamine has. However, addiction can be characterized more as a disorder of compulsion than a disorder of enjoyment. 5-HT mechanisms play key roles in compulsive disorders. Nicotine-induced 5-HT release may be a key to tobacco addiction. Ketanserin, a 5-HT2a and 5-HT2c receptor antagonist, significantly attenuates nicotine effects on attention and memory. These studies were conducted to determine if ketanserin would reduce nicotine self-administration in rats. Male Sprague-Dawley rats (N=12) were given initial food pellet training and then 10 sessions of nicotine self-administration training (0.03 mg/kg/infusion, i.v.). Then the rats were administered ketanserin (1 or 2 mg/kg, s.c.) or the saline vehicle. Ketanserin (2 mg/kg) significantly decreased nicotine self-administration. This did not seem to be due to sedative or amnestic effects of ketanserin. In a second study, the effects of repeated administration of 2 mg/kg ketanserin (N=11) vs. saline injections (N=10) were examined. In the initial phase, the acute effectiveness of ketanserin in significantly reducing nicotine self-administration was replicated. The effect became attenuated during the following several sessions, but the significant effect became re-established during the final phases of this two-week study. 5-HT mechanisms play critical roles in the maintenance of nicotine self-administration. Better understanding of those roles may help lead to new 5-HT-based treatments for tobacco addiction.

Duke Scholars

Published In

Eur J Pharmacol

DOI

EISSN

1879-0712

Publication Date

December 14, 2008

Volume

600

Issue

1-3

Start / End Page

93 / 97

Location

Netherlands

Related Subject Headings

  • Tobacco Use Disorder
  • Serotonin Antagonists
  • Serotonin 5-HT2 Receptor Antagonists
  • Serotonin
  • Self Administration
  • Rats, Sprague-Dawley
  • Rats
  • Pharmacology & Pharmacy
  • Nicotinic Agonists
  • Nicotine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Levin, E. D., Slade, S., Johnson, M., Petro, A., Horton, K., Williams, P., … Rose, J. E. (2008). Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats. Eur J Pharmacol, 600(1–3), 93–97. https://doi.org/10.1016/j.ejphar.2008.10.016
Levin, Edward D., Susan Slade, Michael Johnson, Ann Petro, Kofi Horton, Paul Williams, Amir H. Rezvani, and Jed E. Rose. “Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.Eur J Pharmacol 600, no. 1–3 (December 14, 2008): 93–97. https://doi.org/10.1016/j.ejphar.2008.10.016.
Levin ED, Slade S, Johnson M, Petro A, Horton K, Williams P, et al. Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats. Eur J Pharmacol. 2008 Dec 14;600(1–3):93–7.
Levin, Edward D., et al. “Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.Eur J Pharmacol, vol. 600, no. 1–3, Dec. 2008, pp. 93–97. Pubmed, doi:10.1016/j.ejphar.2008.10.016.
Levin ED, Slade S, Johnson M, Petro A, Horton K, Williams P, Rezvani AH, Rose JE. Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats. Eur J Pharmacol. 2008 Dec 14;600(1–3):93–97.
Journal cover image

Published In

Eur J Pharmacol

DOI

EISSN

1879-0712

Publication Date

December 14, 2008

Volume

600

Issue

1-3

Start / End Page

93 / 97

Location

Netherlands

Related Subject Headings

  • Tobacco Use Disorder
  • Serotonin Antagonists
  • Serotonin 5-HT2 Receptor Antagonists
  • Serotonin
  • Self Administration
  • Rats, Sprague-Dawley
  • Rats
  • Pharmacology & Pharmacy
  • Nicotinic Agonists
  • Nicotine